Posted inCampaigning Community News International Medicines News PrEP Prevention Research Treatment Gilead to support generic lenacapavir in low-income nations Posted by By Tom Hayes-Isaacs 2024-10-08 Earlier this month, Gilead Sciences announced that it had signed non-exclusive, royalty-free voluntary licensing agreements…